期刊文献+

Serum albumin as a prognostic predictor reflecting host immunity in patients with non-small cell lung cancer

下载PDF
导出
摘要 Objective:Serum albumin(ALB)can transport nutrients to circulating and local immune cells by passing through blood vessels and has attracted attention as a prognostic predictor of non-small cell lung cancer(NSCLC)because it reflects the host immunity from peripheral blood(PBL)to the tumor microenvironment. Methods:Clinical data regarding the PBL and tumor tissues were obtained at The First Hospital of Jilin University between February 2009 and March 2017.We detected indices of glucose and lipid metabolism,classified and counted PBL lymphocytes using flow cy-tometry,determined the tumor-infiltrating lymphocytes by quantitative immunofluorescence,and analyzed the T-cell receptor(TCR)rep-ertoire by high-throughput sequencing of the TCR β-chain.The correlations between ALB and metabolic immune indices were analyzed by t tests and Pearson chi-square test. Results:A total of 211 enrolled NSCLC patients were divided into a relatively high-ALB group(>41.75 g/L,n = 56)and a low-ALB group(≤41.75 g/L,n = 155);patients with high ALB had lower Treg cells(P<0.05)and more CD8+ cytotoxic T cells in the PBL(P<0.01)and a higher proportion of stromal CD8+ tumor-infiltrating lymphocytes(P = 0.047)than patients with low ALB.High ALB was also significantly related to more diversity in the TCR repertoire(P = 0.0021,r2 = 0.5481).Moreover,ALB was identified as an in-dependent prognostic factor based on a multivariate Cox regression analysis(P = 0.032;hazard ratio(HR)= 1.804;95%confidence interval(CI)= 1.035-3.146).The median overall survival in patients with low ALB vs high ALB was 28.2 vs 42.2 months(P=0.0142),respectively.Among patients with nonmetastatic NSCLC(stage Ⅰ-Ⅲ),there was a higher incidence of distant metastasis in the low-ALB group than that in the high-ALB group(41.3%and 22.2%,P=0.043).A low ALB also had a strong association with a higher risk for disease progression(P<0.001)and death(P<0.01;HR = 0.555;95%CI= 0.312-0.988). Conclusions:Albumin could affect the host immunity,and high ALB predicted a reduced risk of distant metastasis and improved the prognosis in NSCLC patients.
出处 《Journal of Nutritional Oncology》 2023年第3期136-142,共7页 肿瘤营养学杂志(英文)
基金 supported by Research on Chronic Noncommunicable Diseases Prevention and Control of National Ministry of Science and Technology(No.2016YFC1303804) National Natural Science Foundation of China grant(No.81672275,No.81874052,No.3A214DJ63428)to J-WC the Youth Fund of the National Natural Science Foundation of China(No.81802487) the Youth Development Foundation of The First Hospital of jilin University(No.JDYY92018028)to L-YL.
  • 相关文献

参考文献1

二级参考文献56

  • 1Busher JT. Serum Albumin and Globulin. In: Walker HK, HallWD, Hurst JW, editors. Clinical Methods: The History, Physical,and Laboratory Examinations. 3rd ed. Boston: Butterworths, 1990:Chapter 101 [PMID: 21250048].
  • 2Kennelly PJ, Murray RK, Jacob M, Varghese J. Plasma Proteins& Immunoglobulins. In: Rodwell VW, Bender DA, Botham KM,Kennelly PJ, Weil P editors. Harper's Illustrated Biochemistry,30e. New York, NY: McGraw-Hill, 2015. [Accessed 2015 Jun16]. Available from: URL: http://accessmedicine.mhmedical.com/content.aspx-bookid=1366&Sectionid=73247095.
  • 3Azab BN, Bhatt VR, Vonfrolio S, Bachir R, Rubinshteyn V,Alkaied H, Habeshy A, Patel J, Picon AI, Bloom SW. Value ofthe pretreatment albumin to globulin ratio in predicting long-termmortality in breast cancer patients. Am J Surg 2013; 206: 764-770[PMID: 23866764 DOI: 10.1016/j.amjsurg.2013.03.007].
  • 4Cunha Cde M, Sampaio Ede J, Varj-o ML, Factum CS, RamosLB, Barreto-Medeiros JM. Nutritional assessment in surgicaloncology patients: a comparative analysis between methods.Nutr Hosp 2015; 31: 916-921 [PMID: 25617581 DOI: 10.3305/nh.2015.31.2.7715].
  • 5Anderson CF, Wochos DN. The utility of serum albumin values inthe nutritional assessment of hospitalized patients. Mayo Clin Proc1982; 57: 181-184 [PMID: 6801397].
  • 6Fuhrman MP. The albumin-nutrition connection: separating mythfrom fact. Nutrition 2002; 18: 199-200 [PMID: 11844655].
  • 7Heys SD, Walker LG, Deehan DJ, Eremin OE. Serum albumin:a prognostic indicator in patients with colorectal cancer. J R CollSurg Edinb 1998; 43: 163-168 [PMID: 9654876].
  • 8McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR,McArdle CS. Albumin concentrations are primarily determinedby the body cell mass and the systemic inflammatory response incancer patients with weight loss. Nutr Cancer 2001; 39: 210-213[PMID: 11759282].
  • 9Don BR, Kaysen GA. Assessment of inflammation and nutrition inpatients with end-stage renal disease. J Nephrol 2000; 13: 249-259[PMID: 10946803].
  • 10McMillan DC. Systemic inflammation, nutritional status andsurvival in patients with cancer. Curr Opin Clin Nutr Metab Care2009; 12: 223-226 [PMID: 19318937 DOI: 10.1097/MCO.0b013e32832a7902].

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部